9-12 | Médecins Sans Frontières (MSF) is working to improve sanitation and treating conditions including respiratory infections and water-borne diseases.The Philippines continues to recover after severe flooding caused catastrophic damage in early August. MSF is providing emergency medical assistance in two neighbourhoods where healthcare is particularly difficult to access.
9-11 | Case could negatively impact India’s role as ‘pharmacy of the developing world’
9-5 | German company appeals against life-saving compulsory licence decision in India German pharmaceutical company Bayer today heads to India’s Intellectual Property Appellate Board in Chennai in a bid to overturn a compulsory licence which has allowed more affordable generic versions of sorafenib tosylate, a cancer drug patented by Bayer, to be produced in the interests of public health. International humanitarian health organisation Médecins Sans Frontières has criticised Bayer for the move.
7-30 | Middle-income countries are increasingly taking measures to overcome the patents that price drugs out of reach, according to a new report released from Médecins Sans Frontières (MSF), Untangling the web of Antiretroviral price reductions.
In March, India for the first time issued a ‘compulsory license’ to override a drug patent on the cancer drug sorafenib tosylate, produced by Bayer. The move sets an important precedent for access to ARVs that are unaffordable. China has also just confirmed its mechanism to override patents.
7-30 | Middle-income countries are increasingly taking measures to overcome the patents that price drugs out of reach, according to a new report released from Médecins Sans Frontières (MSF), Untangling the web of Antiretroviral price reductions.
In March, India for the first time issued a ‘compulsory license’ to override a drug patent on the cancer drug sorafenib tosylate, produced by Bayer. The move sets an important precedent for access to ARVs that are unaffordable. China has also just confirmed its mechanism to override patents.